Description
Trade name:
Lolawest
Compound:
Each sachet contains:
L-ornithine L-aspartate 3 g
Properties:
Hypoammonemic agent. Reduces elevated ammonia levels in the body, particularly in liver diseases. The action is associated with participation in the ornithine cycle of Krebs urea formation (formation of urea from ammonia). Promotes the production of insulin and somatotropic hormone. Improves protein metabolism in diseases requiring parenteral nutrition.
Ornithine aspartate in the body dissociates into the amino acids ornithine and aspartate, which are absorbed in the small intestine by active transport through the intestinal epithelium. It is excreted in the urine.
Indications:
Acute and chronic liver diseases accompanied by hyperammonemia. Hepatic encephalopathy.
For dynamic study of pituitary gland function.
As a corrective additive to parenteral nutrition preparations in patients with protein deficiency.
Method of administration and dosage:
For oral administration – 1 sachet 1-2 times a day after meals (dissolve the contents of the sachet in half a glass of water and drink).
The duration and length of treatment are determined individually.
Contraindications:
Severe renal impairment (serum creatinine content greater than 3 mg/100 ml).
Precautions:
When using a specific dosage form of ornithine, it is important to ensure that it is consistent with specific indications.
Impact on the ability to drive vehicles and operate machinery:
Ornithine may cause disturbances in concentration and speed of psychomotor reactions.
Side effects:
Rare: skin manifestations.
In isolated cases: nausea, vomiting.
Storage method:
At a temperature not exceeding 25 degrees.
Package:
The cardboard box contains 6 sachets of 3 g each, paper instructions.
